Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Report from a workshop on multianalyte microsphere assays.

Marie C Earley1, Robert F Vogt, Howard M Shapiro

  • 1Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA. mee9@cdc.gov

Cytometry
|October 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Path to Screening US Newborns for Severe Combined Immunodeficiency, 1968-2018: A Narrative Review of a Successful Biomedical Research and Public Health Partnership.

Public health genomics·2026
Same author

Flow Cytometry: The Glass Is Half Full.

Methods in molecular biology (Clifton, N.J.)·2024
Same author

Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays.

International journal of neonatal screening·2023
Same author

William Harry Hannon-A Life Well Lived.

International journal of neonatal screening·2022
Same author

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.

Leukemia & lymphoma·2021
Same author

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.

Blood·2021

Multiplexed assays with fluorescent microspheres offer a flexible platform for public health research. A workshop highlighted key considerations for developing and implementing these assays, including quality control and commercialization.

Area of Science:

  • Biotechnology
  • Public Health Research
  • Assay Development

Background:

  • Multiplexed assays utilizing fluorescent microspheres are increasingly adopted in public health.
  • The platform's flexibility supports diverse applications like immunoassays and oligonucleotide hybridization.
  • The Centers for Disease Control and Prevention (CDC) convened a workshop to address critical aspects of this technology.

Framework:

  • The Luminex 100 xMAP instrument serves as a key platform for these multiplexed assays.
  • Standardization and best practices are crucial for reliable assay performance.
  • The workshop focused on optimizing assay design and quality control.

Implementation:

  • Discussions covered essential elements for assay development, including instrumentation and sample handling.

Related Experiment Videos

  • Addressing challenges in sample matrix and volume is vital for assay robustness.
  • Quality control measures were emphasized to ensure data accuracy and reproducibility.

    • Implications:

    • Successful implementation of multiplexed assays can enhance disease surveillance and diagnostics.
    • Further development of commercial applications can broaden accessibility and impact.
    • Standardized protocols will facilitate wider adoption and data comparability in public health.